Teacher Retirement System Of Texas Cyma Bay Therapeutics, Inc. Transaction History

Teacher Retirement System Of Texas

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$12.63 - $24.47 $59,424 - $115,131	-4,705 Reduced 20.34%	18,430 $435,000
Q3 2023 Oct 31, 2023	BUY	$10.86 - $17.62 $35,859 - $58,181	3,302 Added 16.65%	23,135 $345,000
Q2 2023 Jul 19, 2023	SELL	$7.47 - $10.95 $46,709 - $68,470	-6,253 Reduced 23.97%	19,833 $217,000
Q1 2023 May 12, 2023	BUY	$5.88 - $9.59 $153,385 - $250,164	26,086 New	26,086 $227,000
Q3 2018 Nov 09, 2018	SELL	$10.88 - $14.52 $122,454 - $163,422	-11,255 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$10.66 - $14.38 $119,978 - $161,846	11,255 New	11,255 $151,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.